-
Essay / Comparison of the European Union, Canada and the United States in terms of cancer treatment and research
Cancers and tumors cost each country a lot of money. In Scotland, the total amount spent on cancer services (excluding cancer screening programs) was around £475 million in 2007. This paper was not only written by three experts in healthcare improvement and economics, it was also published by the Scottish Government. very reliable source. In the United States, however, spending on cancer care is estimated to reach $157 billion. Clearly, there are large variations between cancer spending in different countries around the world, even when those countries have roughly the same level of national income. This source was published by The Lancet Oncology, a medical journal that had the second highest impact factor (79, 258) in 2017. The authors are all experts in this field and work at the Health Economics Research Center and the King's Health Partners Cancer. Center and Institute for Cancer Policy. This source is therefore extremely reliable. However, this same issue of The Lancet Oncology contains an article that explains how inconsistent data quality makes it difficult to accurately compare different countries in terms of healthcare spending and efficiency. Several EU countries that spend less money each year on cancer care actually get better results. This is because they consider better practices in the long term and are therefore more profitable. All these authors are again experts in oncology. Say no to plagiarism. Get a tailor-made essay on “Why Violent Video Games Should Not Be Banned”? Get an original essay So, what are cost-effective cancer treatments? Radiotherapy, which is of great importance in more than half of newly diagnosed cancers, is financially a better choice than surgery and chemotherapy. The source I used on the amount of radiation therapy is over 10 years old. Nevertheless, radiotherapy remains a crucial element in the majority of cancer treatments today. However, as mentioned earlier, countries are investing significantly in the fight against cancer, not only in terms of amount, but also in the manner of investing it. Although EU countries have different investment policies, since 2006 there has been collaboration between all EU countries except Slovakia and Bulgaria. This collaboration is called the European Network for Health Technology Assessment, or EUnetHTA, and values universality, access to good quality care, equity and solidarity. Their goal is not limited to cancer care, but it makes research more accessible and can thus be of great help in making cancer care in more countries better and more cost-effective. Canada approaches health care according to similar principles, namely "Access should be based on need, not ability to pay." “Because care must be accessible to everyone, regardless of their income, it is very important for Canada that their treatment is cost-effective. This is evident in their multiple programs that track progress in the fight against cancer, such as the Cancer Quality Council of Ontario (CQSO). The CQSO is one of the premier health councils in Canada and publishes the Cancer Control System Quality Index (CSQI) each year. In the CSQI, cancer care is monitored according to seven categories: safety; efficiency; accessibility; reactivity.